| Clinical consequences of polypharmacy in elderly | 2013/09/27 | English | 1,010 |
| Long-term side effects of glucocorticoids | 2016/02/06 | English | 447 |
| Paclitaxel: a review of adverse toxicities and novel delivery strategies | 2007/09/01 | English | 322 |
| An update on the clinical consequences of polypharmacy in older adults: a narrative review | 2018/12/02 | English | 277 |
| Statin-induced myopathy: a review and update | 2011/02/23 | English | 209 |
| Hydroxychloroquine in systemic lupus erythematosus (SLE) | 2016/12/14 | English | 206 |
| A review of the efficacy and safety of oral antidiabetic drugs | 2012/12/14 | English | 201 |
| Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis | 2014/08/19 | English | 199 |
| Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis | 2016/12/05 | English | 198 |
| A systematic review of the safety of probiotics | 2014/01/03 | English | 195 |
| Statin use and cancer risk: a comprehensive review | 2010/04/09 | English | 190 |
| Fluoropyrimidine-associated cardiotoxicity: revisited | 2009/03/01 | English | 180 |
| The role of data mining in pharmacovigilance | 2005/09/01 | English | 173 |
| A review of existing and emerging digital technologies to combat the global trade in fake medicines | 2017/04/07 | English | 171 |
| Drug-induced phospholipidosis: issues and future directions | 2006/06/15 | English | 169 |
| Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity | 2005/05/01 | English | 168 |
| Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety | 2006/08/15 | English | 159 |
| Adverse reactions to first-line antituberculosis drugs | 2006/02/27 | English | 158 |
| Renal adverse effects of nonsteroidal anti-inflammatory drugs | 2009/10/15 | English | 158 |
| Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions | 2011/10/25 | English | 157 |
| Hydroxyurea therapy for sickle cell anemia | 2015/09/14 | English | 148 |
| Adverse events associated with mTOR inhibitors | 2012/12/20 | English | 147 |
| Pioglitazone: side effect and safety profile | 2010/02/23 | English | 146 |
| Thiazolidinedione safety | 2012/05/22 | English | 144 |
| Infection risk associated with anti-TNF-α agents: a review | 2015/01/29 | English | 137 |
| Anti-obesity drugs: a review about their effects and their safety | 2012/03/23 | English | 136 |
| Anthracycline cardiotoxicity | 2011/06/02 | English | 134 |
| The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms | 2005/12/22 | English | 131 |
| Safety and tolerability of antipsychotic polypharmacy | 2012/05/08 | English | 128 |
| Weight gain and antipsychotics: a drug safety review | 2014/11/15 | English | 126 |